We proposed a rational design of spatial configurations to develop dioxygenated derivatives that adhere to specific conformational requirements. This strategy is anticipated to enhance the spatial binding affinity of the inhibitors with FabH, aiming to improve binding affinity while concurrently minimizing off-target effects, thereby further augmenting antibacterial efficacy.